Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for GWW on February 4, 2026 01:31PM ET. The previous analyst recommendation was Outperform.GWW was trading at $1155 at issue of the analyst...

February 4, 2026   GWW -0.40%

RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR 1.10%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for PEP on February 4, 2026 12:08PM ET. The previous analyst recommendation was Outperform.PEP was trading at $162.85 at issue of...

February 4, 2026   PEP 0.45%

BMO Capital analyst issues MARKET PERFORM recommendation for ADM on February 4, 2026 12:45PM ET. The previous analyst recommendation was Market Perform.ADM was trading at $67.39 at issue...

February 4, 2026   ADM 1.44%

Barclays analyst issues UNDERWEIGHT recommendation for GWW on February 4, 2026 10:56AM ET. The previous analyst recommendation was Underweight.GWW was trading at $1155 at issue of the analyst...

February 4, 2026   GWW -0.40%

Wells Fargo analyst issues POSITIVE recommendation for EMR on February 4, 2026 11:31AM ET. The previous analyst recommendation was Positive.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR 1.10%

Citigroup analyst issues NEUTRAL recommendation for ITW on February 4, 2026 11:36AM ET. The previous analyst recommendation was Neutral.ITW was trading at $278.91 at issue of the analyst...

February 4, 2026   ITW 1.15%

Citigroup analyst issues BUY recommendation for EMR on February 4, 2026 11:35AM ET. The previous analyst recommendation was Buy.EMR was trading at $152.1 at issue of the analyst...

February 4, 2026   EMR 1.10%

Wells Fargo analyst issues UNDERWEIGHT recommendation for ITW on February 4, 2026 11:37AM ET. The previous analyst recommendation was Underweight.ITW was trading at $278.91 at issue of the...

February 4, 2026   ITW 1.15%

Citigroup analyst issues BUY recommendation for PEP on February 4, 2026 11:39AM ET. The previous analyst recommendation was Buy.PEP was trading at $162.85 at issue of the analyst...

February 4, 2026   PEP 0.45%